IMpower 132: Is the Second Exception to the Rule No Longer an Exception?
- PMID: 33896575
- DOI: 10.1016/j.jtho.2021.01.003
IMpower 132: Is the Second Exception to the Rule No Longer an Exception?
Comment in
-
Response to Letter to the Editor.J Thorac Oncol. 2021 May;16(5):e30-e31. doi: 10.1016/j.jtho.2021.02.018. J Thorac Oncol. 2021. PMID: 33896576 No abstract available.
Comment on
-
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial.J Thorac Oncol. 2021 Apr;16(4):653-664. doi: 10.1016/j.jtho.2020.11.025. Epub 2020 Dec 14. J Thorac Oncol. 2021. PMID: 33333328 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
